Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling

Publisher： John Wiley & Sons Inc

E-ISSN： 1615-9861|15|2-3|532-544

ISSN： 1615-9853

Source： PROTEOMICS, Vol.15, Iss.2-3, 2015-01, pp. : 532-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantitative phosphoproteomic analysis reveals γ‐bisabolene inducing p53‐mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation

By  

PROTEOMICS, Vol. 1615-9853, Iss. 19, 2015-10 ,pp. : 3296-3309

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative phosphoproteomic analysis reveals γ‐bisabolene inducing p53‐mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation

By  

PROTEOMICS, Vol. 15, Iss. 19, 2015-10 ,pp. : 3296-3309

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphoproteomic analysis of basal and therapy‐induced adaptive signaling networks in BRAF and NRAS mutant melanoma

By  

PROTEOMICS, Vol. 15, Iss. 2-3, 2015-01 ,pp. : 327-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells

By  

FEBS JOURNAL (ELECTRONIC), Vol. 280, Iss. 21, 2013-11 ,pp. : 5269-5282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Simultaneous dissection and comparison of IL‐2 and IL‐15 signaling pathways by global quantitative phosphoproteomics

By  

PROTEOMICS, Vol. 15, Iss. 2-3, 2015-01 ,pp. : 520-531

John Wiley & Sons Inc

Access to resources Recommend Favorite